RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway

Prostate cancer (PCa) morbidity in the majority of patients is due to metastatic events, which are a clinical obstacle. Therefore, a better understanding of the mechanism underlying metastasis is imperative if we are to develop novel therapeutic strategies. Receptor activator of nuclear factor kappa...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Mineon, Cho, Yong Jin, Kim, Bora, Ko, Young Jong, Jang, Yuria, Moon, Yeon Hee, Hyun, Hoon, Lim, Wonbong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190078/
https://www.ncbi.nlm.nih.gov/pubmed/34108600
http://dx.doi.org/10.1038/s41598-021-91721-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190078/
https://www.ncbi.nlm.nih.gov/pubmed/34108600
http://dx.doi.org/10.1038/s41598-021-91721-2

Ejemplares similares